Uzbekistan Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Uzbekistan Health News.

Press releases published on October 15, 2026

9 hours ago

Jasper Therapeutics Announces Completion of Enrollment in First Cohort of Phase 2 Renal Basket Study Evaluating Vensobafusp Alfa (KP104) in IgA Nephropathy

Indeterminate GlobeNewswire

9 hours ago

IRulya Therapeutics to Participate in the Craig-Hallum Biotech Catalyst Conference

Indeterminate GlobeNewswire

9 hours ago

Protara Therapeutics Completes Enrollment of the Phase 2b Open-Label Dose Confirmation Phase of the THRIVE-3 Registrational Trial of IV Choline Chloride in Patients on Parenteral Support

Indeterminate GlobeNewswire

9 hours ago

Claris Biotherapeutics to Host Virtual KOL Event on Positive CSB-001 Data and the Unmet Need in Limbal Stem Cell Deficiency (LSCD)

Indeterminate GlobeNewswire

9 hours ago

Humacyte Provides Commercial Update and Highlights Rapid Acceleration of Symvess Adoption by Hospitals

Indeterminate GlobeNewswire

9 hours ago

Eupraxia Pharmaceuticals Reaches its Enrollment Target for the RESOLVE Trial Investigating EP-104GI for the Treatment of Eosinophilic Esophagitis

Indeterminate GlobeNewswire

9 hours ago

ORYZON further strengthens vafidemstat’s patent portfolio with new decisions to grant

Indeterminate GlobeNewswire

9 hours ago

Eikon Therapeutics Submits IND for Novel Androgen Receptor Antagonist EIK1006 in Prostate Cancer

Indeterminate GlobeNewswire

9 hours ago

PETVIVO ANNOUNCES RELEASE OF TWO REASEARCH ABSTRACTS AND UPCOMING CONFERENCE PRESENTATIONS ON OSTEOARTHRITIS IN RHESUS MACAQUES

Indeterminate GlobeNewswire

9 hours ago

First Tracks Biotherapeutics Announces $200 Million Private Placement

Indeterminate GlobeNewswire

9 hours ago

Jyong Biotech Announces Proposed Texas Facility to Support Potential Commercialization of Its Drug Candidates

Indeterminate GlobeNewswire

9 hours ago

PA Nonprofit Launches New Women’s Health Innovation Program to Close Gaps in Healthcare Innovation

Indeterminate GlobeNewswire

9 hours ago

Conavi Medical to Showcase FDA-Cleared Hybrid Imaging System at TCT 2026

Indeterminate GlobeNewswire

9 hours ago

Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors

Indeterminate GlobeNewswire

9 hours ago

Palvella Therapeutics to Present Phase 3 SELVA and Phase 2 TOIVA Results, Along With New Pediatric Analyses, at 2026 PeDRA Annual Conference

Indeterminate GlobeNewswire

10 hours ago

SciSparc Announces Transformation into Agentic AI-Powered Technologies, Including Cybersecurity and Finance Technologies

Indeterminate GlobeNewswire

10 hours ago

Salvia BioElectronics Initiates Pivotal Study with First Patient in the U.S. Receiving Ultra Thin Neuromodulation Implant for Resistant Migraine

Indeterminate GlobeNewswire

10 hours ago

Eindhovens medtechbedrijf Salvia BioElectronics start grootschalige studie in de VS met flinterdunne implantaten tegen migraine

Indeterminate GlobeNewswire

10 hours ago

R1 Therapeutics to present Phase 2b trial-in-progress poster for AP306 at ASN Kidney Week 2026

Indeterminate GlobeNewswire

10 hours ago

Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes

Indeterminate GlobeNewswire